Protalix BioTherapeutics, Inc. (PLX) › Shares OutstandingProtalix BioTherapeutics, Inc. (PLX) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2010: 81.25M2011: 85.63M2012: 93.49M2013: 93.55M2014: 93.60M2015: 99.80M2016: 124.13M2017: 143.73M2018: 14.84M2019: 14.84M2020: 34.77M2021: 45.56M2022: 53.79M2023: 72.95M2024: 75.85M2025: 80.43M80.43M2010Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY202580.43M+6.0%202475.85M+4.0%202372.95M+35.6%202253.79M+18.1%202145.56M+31.0%202034.77M+134.3%201914.84M+0.0%201814.84M-89.7%2017143.73M+15.8%2016124.13M+24.4%201599.80M+6.6%201493.60M+0.1%201393.55M+0.1%201293.49M+9.2%201185.63M+5.4%201081.25M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share